Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use.
Choose from the criteria below to find an activity that fits you best.
|A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)|
Vaccine uptake in underserved populations has lagged far behind Healthy People
2020 goals. Coupled with unique barriers to uptake and a disproportionate amount of
complications from COVID-19, the 2020-2021 flu season may prove particularly deadly
for the black, Hispanic, and Native American populations in the US. The overall rate
of vaccination in US adults falls far below recommended levels. Fortunately, there
is evidence that vaccine initiatives have a positive effect on immunization rates,
increasing access to immunization for the public.
Although pharmacists and other immunizers are well-prepared to identify individuals in need of vaccines and teach patients about vaccines and vaccine-preventable disease, education has not focused on cultural competency or disparities between different minority communities in vaccine uptake. This activity will introduce background knowledge on the clinical impact of low vaccination rates in minorities, social influences that guide individual vaccine decisions, and help to improve comfort in identifying and counseling vulnerable underserved populations.
The target audience for this activity includes pharmacists, nurses, nurse practitioners and physician assistants.
At the completion of this activity, the participant will be able to:
Lakesha M. Butler, PharmD
Clinical Professor, Pharmacy Practice
Director of Diversity, Equity and Inclusion
Southern Illinois University Edwardsville
Bruce L. Lambert, PhD
Director, Center for Communication and Health
Professor, Department of Communication Studies and Medical Social Sciences
Christopher Medlin, PharmD
Clinical Assistant Professor
Department of Pharmacy Practice and Clinical Sciences
School of Pharmacy
The University of Texas at El Paso
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation.
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
ProCE and CCO Planners have no relevant conflicts of interest to report.
Potential conflicts of interest were resolved with a peer review process provided by Cesar Banuelos, PA-C.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Release Date: October 27, 2020
Expiration Date: November 15, 2021
This activity is jointly provided by ProCE, LLC and the Society of Infectious Diseases Pharmacists. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-505-H04-P has been assigned to this home-study knowledge-based activity. This CE activity is approved for 2.0 contact hours (0.2 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
Nurses and Nurse Practitioners
This CE activity is jointly provided by ProCE, LLC and Wild Iris Medical
Education, Inc. This activity provides 2.0 contact hours of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC and ProCE, LLC. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AAPA Credit Designation
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until November 15, 2021. PAs should only claim credit commensurate with the extent of their participation.
This activity is supported by educational grants from Seqirus USA Inc. and GlaxoSmithKline.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.